10-05-2018 | Lorcaserin | EASD 2018 | News
Losing weight in the CAMELLIA-TIMI 61 trial was associated with a significantly reduced risk for developing type 2 diabetes, the investigators have reported at the 54th EASD Annual Meeting in Berlin, Germany.
08-26-2018 | Lorcaserin | Highlight | News
The weight-loss medication lorcaserin neither increases nor reduces cardiovascular risk, report the CAMELLIA–TIMI 61 investigators.
04-03-2018 | Obesity | Review | Article
Byrd AS, Toth AT, Stanford FC. Curr Obes Rep 2018; Advance online publication. doi: 10.1007/s13679-018-0301-3
03-05-2018 | Obesity | Review | Article
Srivastava G, Apovian C. Curr Obes Rep 2018; Advance online publication. doi: 10.1007/s13679-018-0300-4
10-13-2017 | Obesity | Review | Article
Nat Rev Endocrinol 2017; 14: 12–24. doi: 10.1038/nrendo.2017.122